ReviewSkin appendage disorders2026
Revisiting Diffuse Unpatterned Alopecia: Reappraisal of a Controversial Diagnosis.
Review in Skin appendage disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diffuse unpatterned alopecia (DUPA) is an uncommon and incompletely characterized variant of androgenetic alopecia (AGA) marked by diffuse follicular miniaturization across the entire scalp, including the occipital region, which distinguishes it from classic patterned AGA and often precludes hair transplantation. Summary: In this review of the available literature on DUPA, we discuss its clinical presentation, diagnostic features, competing pathophysiologic hypotheses, and management considerations. Current evidence suggests DUPA typically presents with diffuse thinning across all scalp regions, with trichoscopy demonstrating widespread follicular miniaturization without features of scarring alopecia. Diagnosis remains clinical because histopathologic criteria and standardized trichometric thresholds have not been established. Important mimickers include telogen effluvium and diffuse alopecia areata, requiring careful history, examination, trichoscopy, and occasional scalp biopsy. Management is primarily medical, emphasizing stabilization rather than regrowth, and includes topical or oral minoxidil with consideration of adjunctive therapies in selected patients. Key Messages: DUPA is a diffuse, non-patterned hair loss condition affecting the entire scalp, including the occipital region, for which medical management remains the cornerstone of treatment. DUPA remains poorly defined and further clinicopathologic, trichometric, and longitudinal studies are needed to clarify major knowledge gaps, including epidemiology, pathology, diagnostic criteria, and treatment-specific outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.